Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | May 20, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date May 20, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 46,226 |
Ending reported balance
After 2025-05-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-05-20 · Exercise / conversion · Acquired 454 · Balance 45,907 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 2 · 2025-05-20 · Exercise / conversion · Acquired 453 · Balance 46,360 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 3 · 2025-05-20 · Exercise / conversion · Acquired 572 · Balance 46,932 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 4 · 2025-05-21 · Sale · Disposed 706 · Balance 46,226 F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,614 |
Reported balance
After 2025-05-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-05-20 · Exercise / conversion · Disposed 454 · Balance 3,614 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,970 |
Reported balance
After 2025-05-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-20 · Exercise / conversion · Disposed 453 · Balance 9,970 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,488 |
Reported balance
After 2025-05-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-05-20 · Exercise / conversion · Disposed 572 · Balance 19,488 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 706 | $7.59 | $5,355.01 |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,226 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,488 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F4 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,970 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F3 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,614 Underlying: Class A Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 20, 2025 Filed May 22, 2025 16:05 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015297 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,244 | $7.28 | $9,060.05 |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,453 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · derivative · entry 11 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,906 Underlying: Class A Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F8 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · derivative · entry 10 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,184 Underlying: Class A Common Stock · 1,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F7 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% will vest on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. F7 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% will vest on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,060 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,423 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,068 Underlying: Class A Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2025 Filed Apr 23, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-012500 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 16:32 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | ConversionClass B Common Stock · Derivative | 9,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009690 · form4.xml · derivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,914 Underlying: Class A Common Stock · 9,497 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F1 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F2 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 16:32 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | ConversionClass A Common Stock | 9,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009690 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | GrantRestricted Stock Units · Derivative | 4,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008884 · form4.xml · derivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,245 Underlying: Class A Common Stock · 4,245 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest as follows: 25% on April 16, 2025; 25% on July 16, 2025; 25% on October 16, 2025; and 25% on January 16, 2026. F2 · derivative.expiration_date: The RSUs vest as follows: 25% on April 16, 2025; 25% on July 16, 2025; 25% on October 16, 2025; and 25% on January 16, 2026. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 790 | $7.73 | $6,102.75 |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,652 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,632 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F4 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,876 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F3 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,522 Underlying: Class A Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 17:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-008554 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 740 | $13.44 | $9,947.82 |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,963 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,411 Underlying: Class A Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,204 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,329 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,976 Underlying: Class A Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| February 03, 2025 Filed Feb 6, 2025 16:50 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003436 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 645 | $11.72 | $7,558.11 |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,216 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,776 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F4 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,782 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F3 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,430 Underlying: Class A Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 03, 2025 Filed Jan 8, 2025 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-001023 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 741 | $9.64 | $7,146.20 |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,386 F5 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,419 Underlying: Class A Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F4 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,348 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F7 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F7 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,235 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,880 Underlying: Class A Common Stock · 484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 8 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F4 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.